Lund Hemodynamic Lab
1 – 76 of 76
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Letter
-
Mark
Left ventricular dysfunction in pulmonary arterial hypertension is attributed to underfilling rather than intrinsic myocardial disease : a CMR 2D phase contrast study
(
- Contribution to journal › Article
- 2023
-
Mark
Evaluation of the European Society of Cardiology/European Respiratory Society derived three-and four-strata risk stratification models in pulmonary arterial hypertension : Introducing an internet-based risk stratification calculator
(
- Contribution to journal › Article
-
Mark
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
(
- Contribution to journal › Article
-
Mark
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
(
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Extracellular Vesicle-Associated TWEAK Contributes to Vascular Inflammation and Remodeling During Acute Cellular Rejection
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
(
- Contribution to journal › Letter
-
Mark
Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
(
- Contribution to journal › Letter
-
Mark
Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension : A Swedish single-center study
(
- Contribution to journal › Article
- 2022
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
(
- Contribution to journal › Article
-
Mark
Association between central haemodynamics and renal function in advanced heart failure : a nationwide study from Sweden
(
- Contribution to journal › Article
-
Mark
Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients—A Single-Center Study at Skåne University Hospital in Lund
(
- Contribution to journal › Article
-
Mark
Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Bone mineral density in pediatric heart transplanted patients: A retrospective single-centre study at Skåne University Hospital in Lund 1988-2016
(
- Contribution to journal › Article
-
Mark
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery
(
- Contribution to journal › Article
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population
(
- Contribution to journal › Article
-
Mark
Bioactive adrenomedullin for assessment of venous congestion in heart failure
(
- Contribution to journal › Article
-
Mark
Bone health and cardiac transplantation
(
- Contribution to journal › Scientific review
-
Mark
Andfåddhet potentiellt allvarligt – kräver strukturerad utredning
(
- Contribution to journal › Article
-
Mark
Increased biventricular hemodynamic forces in precapillary pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
(
- Contribution to journal › Letter
- 2021
-
Mark
Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
(
- Contribution to journal › Article
-
Mark
Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Echocardiographic assessment of chamber size and ventricular function during the first year after heart transplantation
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Clinical consequences after heart transplantation with reference to osteoporosis, renal function, and immunosuppression. Experiences from Skåne University Hospital in Lund 1988-2019.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
(
- Contribution to journal › Article
-
Mark
Right ventricular stroke work index in adult patients with pulmonary arterial hypertension: -a comparison between echocardiography and right heart catheterization
(
- Contribution to conference › Abstract
- 2020
-
Mark
Deranged Lung Perfusion Pattern in Patients with Heart Failure Normalizes after Heart Transplantation
2020) In Circulation: Cardiovascular Imaging(
- Contribution to journal › Letter
-
Mark
Plasma biomarkers in pulmonary arterial hypertension diagnosis, treatment response and risk stratification - utilizing Lund Cardio Pulmonary Register
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy : a registry-based study
(
- Contribution to journal › Article
-
Mark
Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics
(
- Contribution to journal › Article
-
Mark
Risk assessment in PAH using quantitative CMR tricuspid regurgitation : relation to heart catheterization
(
- Contribution to journal › Article
-
Mark
Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics
(
- Contribution to journal › Article
-
Mark
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial
(
- Contribution to journal › Article
-
Mark
Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
(
- Contribution to journal › Article
-
Mark
Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics
(
- Contribution to journal › Article
-
Mark
Bone Mineral Density in Relation to Chronic Kidney Disease after Heart Transplantation : A Retrospective Single-center Study at Skåne University Hospital in Lund 1988-2016
(
- Contribution to journal › Article
-
Mark
Right ventricular function parameters in pulmonary hypertension: echocardiography vs. cardiac magnetic resonance
(
- Contribution to journal › Article
-
Mark
Increased pulmonary blood volume variation in patients with heart failure compared to healthy controls; a non-invasive, quantitative measure of heart failure
(
- Contribution to journal › Article
-
Mark
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy
(
- Contribution to journal › Article
-
Mark
Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics
(
- Contribution to journal › Article
- 2019
-
Mark
Bone mineral density and osteoporosis in heart transplanted patients : A single-center retrospective study at Skåne University Hospital in Lund 1988-2016
(
- Contribution to journal › Article
-
Mark
Functional Screening Identifies MicroRNA Regulators of Corin Activity and Atrial Natriuretic Peptide Biogenesis
(
- Contribution to journal › Article
-
Mark
Olika tillstånd av pulmonell hypertension ska inte förväxlas : PAH-läkemedel bör inte användas vid pulmonell hypertension på basen av vänstersidig hjärtsjukdom
(
- Contribution to journal › Article
-
Mark
Patientens perspektiv på att leva med PAH eller CTEPH i Sverige : Enkätstudie visar på betydelsen av adekvat och upprepad information
(
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008-2016
(
- Contribution to journal › Article
-
Mark
Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
(
- Contribution to journal › Article
-
Mark
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Profiling of the plasma proteome across different stages of human heart failure
(
- Contribution to journal › Article
- 2018
-
Mark
Pulmonary hypertension related to heart failure and hypoxia. Mechanisms, new treatment strategies and impact on mortality following heart transplantation. Experiences from Skåne University Hospital in Lund
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Adherence and medication belief in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension : A nationwide population-based cohort survey
(
- Contribution to journal › Article
- 2017
-
Mark
The balance between under- and over-immunosuppression after heart transplantation with emphasis on acute cellular rejection and chronic kidney disease. Experiences from Skåne University Hospital in Lund 1988-2010
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Impact of postoperative pulmonary hypertension on outcome after heart transplantation
(
- Contribution to journal › Article
-
Mark
Pulmonell hypertension vanligt vid vänstersidig hjärtsjukdom
(
- Contribution to journal › Article
-
Mark
Effect of Calcineurin Inhibitor-Free Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate after Heart Transplantation
(
- Contribution to journal › Article
-
Mark
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up : Results of a randomized controlled trial (SCHEDULE)
(
- Contribution to journal › Article
-
Mark
Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Acute cellular rejection later than one year after heart transplantation : A single-center retrospective study at Skåne University Hospital in Lund 1988-2010
(
- Contribution to journal › Article
-
Mark
Pulmonell hypertension vanligt vid vänstersidig hjärtsjukdom - Kunskapsläget är dåligt – fler kliniska studier behövs
(
- Contribution to journal › Scientific review
-
Mark
Reference ranges for transthoracic echocardiography following heart transplantation
(
- Contribution to journal › Published meeting abstract
-
Mark
P1451 Gender related differences in echocardiographic findings post heart transplantation -Impact of sex-mismatch on biventricular function
(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Characteristics and survival of adult Swedish PAH and CTEPH patients 2000–2014
(
- Contribution to journal › Article